ECM
PAVM icon

ExodusPoint Capital Management’s PAVmed PAVM Stock Holding History

ExodusPoint Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-42
Closed -$25K – 2315
2022
Q1 		$25K Sell
42
-100
-70% -$74.3K ﹤0.01% 2099
2021
Q4 		$158K Buy
+142
New +$309K ﹤0.01% 1874

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ExodusPoint Capital Management's PAVM Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of PAVmed (PAVM) in Q2 2022, closing a stake of 42 shares — an estimated $25K sold.

ExodusPoint Capital Management first reported a position in PAVM in Q4 2021 and held it in 2 quarters. The position peaked at $158K in Q4 2021. 73 funds tracked by Wall St. Rank hold PAVM as of Q2 2022.

  • ExodusPoint Capital Management reported no remaining PAVmed position as of Q2 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 42 PAVmed shares in Q2 2022, an estimated $25K.
  • ExodusPoint Capital Management first reported a position in PAVmed in Q4 2021 and held it in 2 quarters.
  • ExodusPoint Capital Management's PAVmed position peaked at $158K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held PAVmed as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.